146 related articles for article (PubMed ID: 19640273)
1. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Canzian F; Kaaks R; Cox DG; Henderson KD; Henderson BE; Berg C; Bingham S; Boeing H; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover R; Hunter DJ; Isaacs C; Lenner P; Lund E; Overvad K; Palli D; Pearce CL; Quiros JR; Riboli E; Stram DO; Thomas G; Thun MJ; Trichopoulos D; van Gils CH; Ziegler RG
BMC Cancer; 2009 Jul; 9():257. PubMed ID: 19640273
[TBL] [Abstract][Full Text] [Related]
2. Determination of sequence variation and haplotype structure for the gonadotropin-releasing hormone (GnRH) and GnRH receptor genes: investigation of role in pubertal timing.
Sedlmeyer IL; Pearce CL; Trueman JA; Butler JL; Bersaglieri T; Read AP; Clayton PE; Kolonel LN; Henderson BE; Hirschhorn JN; Palmert MR
J Clin Endocrinol Metab; 2005 Feb; 90(2):1091-9. PubMed ID: 15546906
[TBL] [Abstract][Full Text] [Related]
3. Haplotypes of the estrogen receptor beta gene and breast cancer risk.
; Cox DG; Bretsky P; Kraft P; Pharoah P; Albanes D; Altshuler D; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Calle EE; Canzian F; Chanock S; Clavel-Chapelon F; Colditz GA; Feigelson HS; Haiman CA; Hankinson SE; Hirschhorn J; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; LeMarchand L; Lund E; Palli D; Peeters PH; Pike MC; Riboli E; Stram DO; Thun M; Tjonneland A; Travis RC; Trichopoulos D; Yeager M
Int J Cancer; 2008 Jan; 122(2):387-92. PubMed ID: 17935138
[TBL] [Abstract][Full Text] [Related]
4. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M;
Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3).
Beckmann L; Hüsing A; Setiawan VW; Amiano P; Clavel-Chapelon F; Chanock SJ; Cox DG; Diver R; Dossus L; Feigelson HS; Haiman C; Hallmans G; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw K; Kolonel LN; Kraft P; Lund E; Le Marchand L; Peeters PH; Riboli E; Stram D; Thomas G; Thun MJ; Tumino R; Trichopoulos D; Vogel U; Willett WC; Yeager M; Ziegler R; Hankinson SE; Kaaks R;
J Clin Endocrinol Metab; 2011 Feb; 96(2):E360-7. PubMed ID: 21177793
[TBL] [Abstract][Full Text] [Related]
7. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
Travis RC; Schumacher F; Hirschhorn JN; Kraft P; Allen NE; Albanes D; Berglund G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Calle EE; Chanock S; Dunning AM; Hayes R; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Kaaks R; Kolonel LN; Ma J; Rodriguez L; Riboli E; Stampfer M; Stram DO; Thun MJ; Tjønneland A; Trichopoulos D; Vineis P; Virtamo J; Le Marchand L; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2734-44. PubMed ID: 19789370
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS
Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
10. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
[TBL] [Abstract][Full Text] [Related]
11. Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs.
Cordeddu L; Bergvall M; Sand E; Roth B; Papadaki E; Li L; D'Amato M; Ohlsson B
Scand J Gastroenterol; 2015 Mar; 50(3):291-9. PubMed ID: 25592315
[TBL] [Abstract][Full Text] [Related]
12. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
[TBL] [Abstract][Full Text] [Related]
13. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Setiawan VW; Schumacher FR; Haiman CA; Stram DO; Albanes D; Altshuler D; Berglund G; Buring J; Calle EE; Clavel-Chapelon F; Cox DG; Gaziano JM; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn J; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Ma J; Le Marchand L; Linseisen J; Lund E; Navarro C; Overvad K; Palli D; Peeters PH; Pike MC; Riboli E; Stampfer MJ; Thun MJ; Travis R; Trichopoulos D; Yeager M; Ziegler RG; Spencer Feigelson H; Chanock SJ
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2237-46. PubMed ID: 18006912
[TBL] [Abstract][Full Text] [Related]
14. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the HSD17B1 gene and risk of prostate cancer.
Kraft P; Pharoah P; Chanock SJ; Albanes D; Kolonel LN; Hayes RB; Altshuler D; Andriole G; Berg C; Boeing H; Burtt NP; Bueno-de-Mesquita B; Calle EE; Cann H; Canzian F; Chen YC; Crawford DE; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Gonzalez CA; Haiman CA; Hallmans G; Henderson BE; Hirschhorn JN; Hunter DJ; Kaaks R; Key T; Le Marchand L; Ma J; Overvad K; Palli D; Pike MC; Riboli E; Rodriguez C; Setiawan WV; Stampfer MJ; Stram DO; Thomas G; Thun MJ; Travis R; Trichopoulou A; Virtamo J; Wacholder S
PLoS Genet; 2005 Nov; 1(5):e68. PubMed ID: 16311626
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphisms in the regulatory region of gonadotropin-releasing hormone receptor gene and breast cancer susceptibility.
Lattrich C; Müller AK; Schüler S; Häring J; Ruoff A; Treeck O; Ortmann O
Oncol Rep; 2012 Sep; 28(3):1091-5. PubMed ID: 22710726
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
18. Autosomal recessive idiopathic hypogonadotropic hypogonadism: genetic analysis excludes mutations in the gonadotropin-releasing hormone (GnRH) and GnRH receptor genes.
Bo-Abbas Y; Acierno JS; Shagoury JK; Crowley WF; Seminara SB
J Clin Endocrinol Metab; 2003 Jun; 88(6):2730-7. PubMed ID: 12788881
[TBL] [Abstract][Full Text] [Related]
19. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive evaluation of ESR2 variation and ovarian cancer risk.
Leigh Pearce C; Near AM; Butler JL; Van Den Berg D; Bretsky P; Conti DV; Stram DO; Pike MC; Hirschhorn JN; Wu AH
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):393-6. PubMed ID: 18268123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
